News Novartis Eye Drug Works With Fewer Injections Than Rivals by Medscape • 2017/06/22 • 0 Comments A drug developed by Novartis to treat vision loss in people over 65 does not need to be injected as frequently as a rival medicine from Regeneron to be effective, clinical trials showed on Tuesday. Reuters Health Information Full Story →